Brad S Kahl (Brad Kahl)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 61

Top Topics

Hodgkin Lymphoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Cody A Ramirez, Michelle Becker-Hapak, Kartik Singhal, David A Russler-Germain, Felix E Frenkel, Erica K Barnell, Ethan D McClain, Sweta Desai, Timothy Schappe, Onyinyechi C Onyeador, Olga Mikhaylovna Plotnikova, Vladislav Belousov, Alexander V Bagaev, Elena Ocheredko, Susanna Kiwala, Jasreet Hundal, Zachary L Skidmore, Marcus P Watkins, Thomas B Mooney, Jason R Walker, Kilannin Krysiak, Felicia Gomez, Catrina C Fronick, Robert S Fulton, Robert D Schreiber, Neha Mehta-Shah, Amanda F Cashen, Brad S Kahl, Ravshan I Ataullakhanov, Nancy L Bartlett, Malachi Griffith, Malachi Griffith, Todd A Fehniger
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma. Blood advances 8 (15) (2024)
Cody A Ramirez, Michelle Becker-Hapak, Kartik Singhal, David A Russler-Germain, Felix E Frenkel, Erica K Barnell, Ethan McClain, Sweta Desai, Timothy Schappe, Onyinyechi C Onyeador, Olga Mikhaylovna Plotnikova, Vladislav Belousov, Alexander V Bagaev, Elena Ocheredko, Susanna Kiwala, Jasreet Hundal, Zachary L Skidmore, Marcus P Watkins, Thomas B Mooney, Jason R Walker, Kilannin Krysiak, Felicia Gomez, Catrina C Fronick, Robert S Fulton, Robert D Schreiber, Neha Mehta-Shah, Amanda F Cashen, Brad S Kahl, Ravshan I Ataullakhanov, Nancy L Bartlett, Malachi Griffith, Malachi Griffith, Todd A Fehniger
Neoantigen Landscape Supports Feasibility of Personalized Cancer Vaccine for Follicular Lymphoma. Blood advances (2024)
Tracy T Batchelor, Sharmila Giri, Amy S Ruppert, Susan M Geyer, Scott E Smith, Nimish Mohile, Lode J Swinnen, Jonathan W Friedberg, Brad S Kahl, Nancy L Bartlett, Eric D Hsi, Bruce D Cheson, Nina D Wagner-Johnston, Lakshmi Nayak, John P Leonard, James L Rubenstein
Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101. Blood advances 8 (12) (2024)
Brad S Kahl, Opeyemi A Jagede, Christopher Peterson, Lode J Swinnen, Thomas M Habermann, Stephen J Schuster, Matthias Weiss, Paul A Fishkin, Timothy S Fenske, Michael E Williams
Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (7) (2024)
Brad S Kahl, Opeyemi A Jagede, Christopher Peterson, Lode J Swinnen, Thomas M Habermann, Stephen J Schuster, Matthias Weiss, Paul A Fishkin, Timothy S Fenske, Michael E Williams
Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Tracy T Batchelor, Sharmila Giri, Amy S Ruppert, Susan Geyer, Scott E Smith, Nimish Mohile, Lode J Swinnen, Jonathan W Friedberg, Brad S Kahl, Nancy L Bartlett, Eric D Hsi, Bruce David Cheson, Nina D Wagner-Johnston, Lakshmi Nayak, John P Leonard, James Louis Rubenstein
Myeloablative Vs. Non-Myeloablative Consolidation for Primary Central Nervous System Lymphoma: Results of Alliance 51101. Blood advances (2024)
Victoria Shelton, Rajesh Detroja, Ting Liu, Keren Isaev, Anjali Silva, Verena Passerini, Mehran Bakhtiari, Lourdes Calvente, Michael Hong, Michael Y He, Saloni Modi, Samantha A Hershenfeld, Maja Ludvigsen, Charlotte Madsen, Stephen Hamilton-Dutoit, Francesco Annibale d'Amore, Marianne Brodtkorb, Nathalie A Johnson, Tara Baetz, David LeBrun, Josh W D Tobin, Maher K Gandhi, Andrew J Mungall, Wei Xu, Susana Ben-Neriah, Christian Steidl, Jan Delabie, Rosemarie Tremblay-LeMay, Opeyemi Jegede, Oliver Weigert, Brad S Kahl, Andrew M Evens, Robert Kridel
Identification of genetic subtypes in follicular lymphoma. Blood cancer journal 14 (1) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
Cody A Ramirez, Michelle Becker-Hapak, Kartik Singhal, David A Russler-Germain, Felix E Frenkel, Erica K Barnell, Ethan D McClain, Sweta Desai, Timothy Schappe, Onyinyechi C Onyeador, Olga Mikhaylovna Plotnikova, Vladislav Belousov, Alexander V Bagaev, Elena Ocheredko, Susanna Kiwala, Jasreet Hundal, Zachary L Skidmore, Marcus P Watkins, Thomas B Mooney, Jason R Walker, Kilannin Krysiak, Felicia Gomez, Catrina C Fronick, Robert S Fulton, Robert D Schreiber, Neha Mehta-Shah, Amanda F Cashen, Brad S Kahl, Ravshan I Ataullakhanov, Nancy L Bartlett, Malachi Griffith, Malachi Griffith, Todd A Fehniger
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma. Blood advances 8 (15) (2024)
Cody A Ramirez, Michelle Becker-Hapak, Kartik Singhal, David A Russler-Germain, Felix E Frenkel, Erica K Barnell, Ethan McClain, Sweta Desai, Timothy Schappe, Onyinyechi C Onyeador, Olga Mikhaylovna Plotnikova, Vladislav Belousov, Alexander V Bagaev, Elena Ocheredko, Susanna Kiwala, Jasreet Hundal, Zachary L Skidmore, Marcus P Watkins, Thomas B Mooney, Jason R Walker, Kilannin Krysiak, Felicia Gomez, Catrina C Fronick, Robert S Fulton, Robert D Schreiber, Neha Mehta-Shah, Amanda F Cashen, Brad S Kahl, Ravshan I Ataullakhanov, Nancy L Bartlett, Malachi Griffith, Malachi Griffith, Todd A Fehniger
Neoantigen Landscape Supports Feasibility of Personalized Cancer Vaccine for Follicular Lymphoma. Blood advances (2024)
Edgar G Kozlova, Hsin-Hui Huang, Opeyemi A Jagede, Kevin Tuballes, Diane M Del Valle, Geoffrey Kelly, Manishkumar Patel, Hui Xie, Jocelyn Harris, Kimberly Argueta, Kai Nie, Vanessa Barcessat, Radim Moravec, Jennifer Altreuter, Dzifa Yawa Duose, Brad S Kahl, Stephen M Ansell, Joyce Yu, Ethan Cerami, James R Lindsay, Ignacio I Wistuba, Seunghee Kim-Schulze, Catherine S Diefenbach, Sacha Gnjatic
Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma. Cancer research communications 4 (7) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology (2024)
Victoria Shelton, Rajesh Detroja, Ting Liu, Keren Isaev, Anjali Silva, Verena Passerini, Mehran Bakhtiari, Lourdes Calvente, Michael Hong, Michael Y He, Saloni Modi, Samantha A Hershenfeld, Maja Ludvigsen, Charlotte Madsen, Stephen Hamilton-Dutoit, Francesco Annibale d'Amore, Marianne Brodtkorb, Nathalie A Johnson, Tara Baetz, David LeBrun, Josh W D Tobin, Maher K Gandhi, Andrew J Mungall, Wei Xu, Susana Ben-Neriah, Christian Steidl, Jan Delabie, Rosemarie Tremblay-LeMay, Opeyemi Jegede, Oliver Weigert, Brad S Kahl, Andrew M Evens, Robert Kridel
Identification of genetic subtypes in follicular lymphoma. Blood cancer journal 14 (1) (2024)
Brad S Kahl, Opeyemi A Jagede, Christopher Peterson, Lode J Swinnen, Thomas M Habermann, Stephen J Schuster, Matthias Weiss, Paul A Fishkin, Timothy S Fenske, Michael E Williams
Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (7) (2024)
Edgar G Kozlova, Hsin-Hui Huang, Opeyemi A Jagede, Kevin Tuballes, Diane M Del Valle, Geoffrey Kelly, Manishkumar Patel, Hui Xie, Jocelyn Harris, Kimberly Argueta, Kai Nie, Vanessa Barcessat, Radim Moravec, Jennifer Altreuter, Dzifa Yawa Duose, Brad S Kahl, Stephen M Ansell, Joyce Yu, Ethan Cerami, James R Lindsay, Ignacio I Wistuba, Seunghee Kim-Schulze, Catherine S Diefenbach, Sacha Gnjatic
Tumor-immune signatures of treatment resistance to brentuximab vedotin with ipilimumab and/or nivolumab in Hodgkin lymphoma. Cancer research communications (2024)
Brad S Kahl, Opeyemi A Jagede, Christopher Peterson, Lode J Swinnen, Thomas M Habermann, Stephen J Schuster, Matthias Weiss, Paul A Fishkin, Timothy S Fenske, Michael E Williams
Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (7) (2024)
Tracy T Batchelor, Sharmila Giri, Amy S Ruppert, Susan M Geyer, Scott E Smith, Nimish Mohile, Lode J Swinnen, Jonathan W Friedberg, Brad S Kahl, Nancy L Bartlett, Eric D Hsi, Bruce D Cheson, Nina D Wagner-Johnston, Lakshmi Nayak, John P Leonard, James L Rubenstein
Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101. Blood advances 8 (12) (2024)
Victoria Shelton, Rajesh Detroja, Ting Liu, Keren Isaev, Anjali Silva, Verena Passerini, Mehran Bakhtiari, Lourdes Calvente, Michael Hong, Michael Y He, Saloni Modi, Samantha A Hershenfeld, Maja Ludvigsen, Charlotte Madsen, Stephen Hamilton-Dutoit, Francesco Annibale d'Amore, Marianne Brodtkorb, Nathalie A Johnson, Tara Baetz, David LeBrun, Josh W D Tobin, Maher K Gandhi, Andrew J Mungall, Wei Xu, Susana Ben-Neriah, Christian Steidl, Jan Delabie, Rosemarie Tremblay-LeMay, Opeyemi Jegede, Oliver Weigert, Brad S Kahl, Andrew M Evens, Robert Kridel
Identification of genetic subtypes in follicular lymphoma. Blood cancer journal 14 (1) (2024)
Cody A Ramirez, Michelle Becker-Hapak, Kartik Singhal, David A Russler-Germain, Felix E Frenkel, Erica K Barnell, Ethan D McClain, Sweta Desai, Timothy Schappe, Onyinyechi C Onyeador, Olga Mikhaylovna Plotnikova, Vladislav Belousov, Alexander V Bagaev, Elena Ocheredko, Susanna Kiwala, Jasreet Hundal, Zachary L Skidmore, Marcus P Watkins, Thomas B Mooney, Jason R Walker, Kilannin Krysiak, Felicia Gomez, Catrina C Fronick, Robert S Fulton, Robert D Schreiber, Neha Mehta-Shah, Amanda F Cashen, Brad S Kahl, Ravshan I Ataullakhanov, Nancy L Bartlett, Malachi Griffith, Malachi Griffith, Todd A Fehniger
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma. Blood advances 8 (15) (2024)
Cody A Ramirez, Michelle Becker-Hapak, Kartik Singhal, David A Russler-Germain, Felix E Frenkel, Erica K Barnell, Ethan D McClain, Sweta Desai, Timothy Schappe, Onyinyechi C Onyeador, Olga Mikhaylovna Plotnikova, Vladislav Belousov, Alexander V Bagaev, Elena Ocheredko, Susanna Kiwala, Jasreet Hundal, Zachary L Skidmore, Marcus P Watkins, Thomas B Mooney, Jason R Walker, Kilannin Krysiak, Felicia Gomez, Catrina C Fronick, Robert S Fulton, Robert D Schreiber, Neha Mehta-Shah, Amanda F Cashen, Brad S Kahl, Ravshan I Ataullakhanov, Nancy L Bartlett, Malachi Griffith, Malachi Griffith, Todd A Fehniger
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma. Blood advances 8 (15) (2024)
Edgar G Kozlova, Hsin-Hui Huang, Opeyemi A Jagede, Kevin Tuballes, Diane M Del Valle, Geoffrey Kelly, Manishkumar Patel, Hui Xie, Jocelyn Harris, Kimberly Argueta, Kai Nie, Vanessa Barcessat, Radim Moravec, Jennifer Altreuter, Dzifa Yawa Duose, Brad S Kahl, Stephen M Ansell, Joyce Yu, Ethan Cerami, James R Lindsay, Ignacio I Wistuba, Seunghee Kim-Schulze, Catherine S Diefenbach, Sacha Gnjatic
Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma. Cancer research communications 4 (7) (2024)
Mitchell Reed Smith, Opeyemi A Jagede, Peter Martin, Brian Till, Samir Parekh, David T Yang, Eric D Hsi, Thomas E Witzig, Sandeep S Dave, David W Scott, Curtis A Hanson, Lale Kostakoglu, Nizar N Abdel Samad, Carla Casulo, Nancy L Bartlett, Paolo F Caimi, Tareq Al Baghdadi, Kristie Blum, Mark Romer, David J Inwards, Rachel Lerner, Lynne I Wagner, Richard F Little, Jonathan W Friedberg, John P Leonard, Brad S Kahl
Randomized Bendamustine-Rituximab(R) + Bortezomib Induction and R + Lenalidomide Maintenance for Mantle Cell Lymphoma. Blood (2024)
Tracy T Batchelor, Sharmila Giri, Amy S Ruppert, Susan M Geyer, Scott E Smith, Nimish Mohile, Lode J Swinnen, Jonathan W Friedberg, Brad S Kahl, Nancy L Bartlett, Eric D Hsi, Bruce D Cheson, Nina D Wagner-Johnston, Lakshmi Nayak, John P Leonard, James L Rubenstein
Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101. Blood advances 8 (12) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
Tracy T Batchelor, Sharmila Giri, Amy S Ruppert, Susan M Geyer, Scott E Smith, Nimish Mohile, Lode J Swinnen, Jonathan W Friedberg, Brad S Kahl, Nancy L Bartlett, Eric D Hsi, Bruce D Cheson, Nina D Wagner-Johnston, Lakshmi Nayak, John P Leonard, James L Rubenstein
Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101. Blood advances 8 (12) (2024)
Tracy T Batchelor, Sharmila Giri, Amy S Ruppert, Susan Geyer, Scott E Smith, Nimish Mohile, Lode J Swinnen, Jonathan W Friedberg, Brad S Kahl, Nancy L Bartlett, Eric D Hsi, Bruce David Cheson, Nina D Wagner-Johnston, Lakshmi Nayak, John P Leonard, James Louis Rubenstein
Myeloablative Vs. Non-Myeloablative Consolidation for Primary Central Nervous System Lymphoma: Results of Alliance 51101. Blood advances (2024)
Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji, Loretta J Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy L Bartlett, Victoria Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua D Brody, Jeremy S Abramson, Matthew A Lunning, Nirav N Shah, Ayed Ayed, Manali Kamdar, Benjamin Parsons, Paolo F Caimi, Ian W Flinn, Alex F Herrera, Jeffrey Sharman, Marshall McKenna, Philippe Armand, Brad S Kahl, Sonali M Smith, Andrew D Zelenetz, L Elizabeth Elizabeth Budde, Martin Hutchings, Tycel Jovelle Phillips, Michael J Dickinson
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy. Blood 143 (16) (2024)
Edgar G Kozlova, Hsin-Hui Huang, Opeyemi A Jagede, Kevin Tuballes, Diane M Del Valle, Geoffrey Kelly, Manishkumar Patel, Hui Xie, Jocelyn Harris, Kimberly Argueta, Kai Nie, Vanessa Barcessat, Radim Moravec, Jennifer Altreuter, Dzifa Yawa Duose, Brad S Kahl, Stephen M Ansell, Joyce Yu, Ethan Cerami, James R Lindsay, Ignacio I Wistuba, Seunghee Kim-Schulze, Catherine S Diefenbach, Sacha Gnjatic
Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma. Cancer research communications 4 (7) (2024)
Tracy T Batchelor, Sharmila Giri, Amy S Ruppert, Susan M Geyer, Scott E Smith, Nimish Mohile, Lode J Swinnen, Jonathan W Friedberg, Brad S Kahl, Nancy L Bartlett, Eric D Hsi, Bruce D Cheson, Nina D Wagner-Johnston, Lakshmi Nayak, John P Leonard, James L Rubenstein
Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101. Blood advances 8 (12) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
Brad S Kahl, Opeyemi A Jagede, Christopher Peterson, Lode J Swinnen, Thomas M Habermann, Stephen J Schuster, Matthias Weiss, Paul A Fishkin, Timothy S Fenske, Michael E Williams
Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (7) (2024)
Rahul Lakhotia, Kieron Dunleavy, Jeremy S Abramson, Brian L Link, Bayard L Powell, Christopher Melani, Andrea Nicole Lucas, Seth M Steinberg, Jonathan W Friedberg, Brad S Kahl, Richard F Little, Nancy L Bartlett, Ariela Noy, Wyndham H Wilson, Mark J Roschewski
Prognostic Factors for Adult Burkitt Lymphoma Patients Treated with Dose-Adjusted EPOCH-R. Blood advances (2023)
Juan Pablo Alderuccio, Isildinha M Reis, Mehdi Hamadani, Muthiah Nachiappan, Salman Leslom, Brad S Kahl, Weiyun Z Ai, John Radford, Melham M Solh, Kirit M Ardeshna, Brian T Hess, Matthew A Lunning, Pier Luigi Luigi Zinzani, Anastasios Stathis, Carmello Carlo-Stella, Izidore S Lossos, Paolo F Caimi, Sunwoo Han, Fei Yang, Russ A Kuker, Craig H Moskowitz
PET/CT-biomarkers enable risk stratification of patients with relapsed/refractory diffuse large B-cell lymphoma enrolled in the LOTIS-2 clinical trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Juan Pablo Alderuccio, Isildinha M Reis, Jean L Koff, Melissa C Larson, Dai Chihara, Wei Zhao, Sara Haddadi, Thomas M Habermann, Peter Martin, Jennifer Chapman, Christopher S Strouse, Brad S Kahl, Jonathon B Cohen, Jonathan W Friedberg, James R Cerhan, Christopher R Flowers, Izidore S Lossos
Predictive value of staging PET/CT to detect bone marrow involvement and early outcomes in marginal zone lymphoma. Blood (2023)
Mehdi Hamadani, Alexander I Spira, Xiaolei Zhou, Laura Liao, Lei Chen, John Radford, Weiyun Z Ai, Melhem M Solh, Kirit M Ardeshna, Brian T Hess, Paolo F Caimi, Anastasios Stathis, Carmelo Carlo Stella, Juan Pablo Alderuccio, Brad S Kahl, Ying Wang, Yajuan Gu Qin, Zhiying Cindy Xu, Pier Luigi Luigi Zinzani
Clinical Outcomes of Older and Younger Patients Treated with Loncastuximab Tesirine in the LOTIS-2 Clinical Trial. Blood advances (2023)
Felicia Gomez, Bryan Fisk, Joshua F McMichael, Matthew Mosior, Jennifer A Foltz, Zachary L Skidmore, Eric J Duncavage, Christopher A Miller, Haley J Abel, Yi-Shan Lee, Kilannin Krysiak, David A Russler-Germain, Marcus P Watkins, Cody A Ramirez, Alina D Schmidt, Fernanda Martins Rodrigues, Lee Trani, Ajay Khanna, Julia A Wagner, Robert S Fulton, Catrina C Fronick, Michelle D O'Laughlin, Timothy Schappe, Amanda F Cashen, Neha Mehta-Shah, Brad S Kahl, Jason R Walker, Nancy L Bartlett, Malachi Griffith, Todd A Fehniger, Malachi Griffith
Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma. Cancer research communications (2023)
David A Russler-Germain, Kilannin Krysiak, Cody A Ramirez, Matthew Mosior, Marcus P Watkins, Felicia Gomez, Zachary L Skidmore, Lee Trani, Feng Gao, Susan Geyer, Amanda F Cashen, Neha Mehta-Shah, Brad S Kahl, Nancy L Bartlett, Juan Pablo Alderuccio, Izidore S Lossos, Sarah L Ondrejka, Eric D Hsi, Peter Martin, John P Leonard, Malachi Griffith, Malachi Griffith, Todd A Fehniger
Mutations Associated with Progression in Follicular Lymphoma Predict Inferior Outcomes at Diagnosis (Alliance A151303). Blood advances (2023)
Kartik Singhal, Marcus P Watkins, Todd A Fehniger, Malachi Griffith, Malachi Griffith, Brad S Kahl, David A Russler-Germain
Donor-Derived Follicular Lymphoma After Kidney Transplantation: A Case Report. JCO precision oncology 7 (2023)
Yazeed Sawalha, Subir Goyal, Jeffrey M Switchenko, Jason T Romancik, Manali Kamdar, Irl Brian Greenwell, Brian T Hess, Krista M Isaac, Craig A Portell, Alex V Mejia Garcia, Scott R Goldsmith, Natalie S Grover, Peter A Riedell, Reem Karmali, Madelyn Burkart, Michael J Buege, Othman S Akhtar, Pallawi Torka, Anita Kumar, Brian T Hill, Brad S Kahl, Jonathon B Cohen
A Multicenter Analysis of the Outcomes with Venetoclax in Patients with Relapsed Mantle Cell Lymphoma. Blood advances (2023)
Juan Pablo Alderuccio, Isildinha M Reis, Jean L Koff, Melissa C Larson, Dai Chihara, Wei Zhao, Sara Haddadi, Thomas M Habermann, Peter Martin, Jennifer Chapman, Christopher S Strouse, Brad S Kahl, Jonathon B Cohen, Jonathan W Friedberg, James R Cerhan, Christopher R Flowers, Izidore S Lossos
Predictive value of staging PET/CT to detect bone marrow involvement and early outcomes in marginal zone lymphoma. Blood (2023)
Narendranath Epperla, Jeffrey M Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie Sophia Grover, Stephanie P Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T Hill, Nilanjan Ghosh, Steven I Park, David A Bond, Mehdi Hamadani, Timothy S Fenske, Peter Martin, Jin Guo, Mary-Kate Malecek, Brad S Kahl, Christopher R Flowers, Brian L Link, Lawrence D Kaplan, David J Inwards, Andrew L Feldman, Eric D Hsi, Kami Maddocks, Kristie Blum, Nancy L Bartlett, James R Cerhan, John P Leonard, Thomas M Habermann, Matthew John Maurer, Jonathon B Cohen
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma. Blood advances (2022)
Narendranath Epperla, Jeffrey M Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie Sophia Grover, Stephanie P Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T Hill, Nilanjan Ghosh, Steven I Park, David A Bond, Mehdi Hamadani, Timothy S Fenske, Peter Martin, Jin Guo, Mary-Kate Malecek, Brad S Kahl, Christopher R Flowers, Brian L Link, Lawrence D Kaplan, David J Inwards, Andrew L Feldman, Eric D Hsi, Kami Maddocks, Kristie Blum, Nancy L Bartlett, James R Cerhan, John P Leonard, Thomas M Habermann, Matthew John Maurer, Jonathon B Cohen
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma. Blood advances (2022)
R Andrew Harkins, Sharvil Piyush Patel, Michelle J Lee, Jeffrey M Switchenko, Stephen M Ansell, Nancy L Bartlett, Kristie A Blum, Amanda F Cashen, Carla Casulo, Jonathan W Friedberg, Patrick B Johnston, Brad S Kahl, John P Leonard, Brian L Link, Izidore S Lossos, Peter Martin, Matthew John Maurer, Neha Mehta-Shah, Patrick M Reagan, Jason R Westin, Jean L Koff, Christopher R Flowers
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey. Blood advances 6 (9) (2022)
David A Bond, Jeffrey M Switchenko, Diego R Villa, Kami Maddocks, Michael Churnetski, Alina S Gerrie, Subir Goyal, Krithika Shanmugasundaram, Oscar Calzada, Bhaskar C Kolla, Veronika Bachanova, James N Gerson, Stefan K Barta, Brian T Hill, Yazeed Sawalha, Peter Martin, Edward B Maldonado, Max J Gordon, Alexey V Danilov, Natalie Sophia Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Nilanjan Ghosh, Steven I Park, Narendranath Epperla, Talha Badar, Jin Guo, Mehdi Hamadani, Timothy S Fenske, Mary-Kate Malecek, Brad S Kahl, Christopher R Flowers, Kristie A Blum, Jonathon B Cohen
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy. Blood advances 5 (23) (2022)
Juan Pablo Alderuccio, Luca Arcaini, Marcus P Watkins, Anne W Beaven, Geoffrey Shouse, Narendranath Epperla, Michele Spina, Alexandra Stefanovic, Jose Sandoval-Sus, Pallawi Torka, Ash B Alpert, Adam J Olszewski, Seo-Hyun Kim, Brian Hess, Sameh Gaballa, Sabarish Ayyappan, Jorge J Castillo, Lisa Argnani, Timothy J Voorhees, Raya Saba, Sayan Mullick Chowdhury, Fernando Vargas, Isildinha M Reis, Deukwoo Kwon, Jonathan Struan Alexander, Wei Zhao, Dali Edwards, Peter Martin, Emanuele Cencini, Manali Kamdar, Brian L Link, Constantine N Logothetis, Alex F Herrera, Jonathan W Friedberg, Brad S Kahl, Stefano Luminari, Pier Luigi Luigi Zinzani, Izidore S Lossos
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma. Blood advances 6 (7) (2022)
Danny Luan, Tolulope Fatola, Ahmed Toure, Christopher R Flowers, Brian L Link, Jonathan W Friedberg, Jonathon B Cohen, Brad S Kahl, Izidore S Lossos, Loretta Nastoupil, Matthew John Maurer, James R Cerhan, Peter Martin
Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysis. Blood advances 6 (15) (2022)
Peter Martin, Jonathon B Cohen, Michael L Wang, Anita Kumar, Brian Hill, Diego R Villa, Jeffrey M Switchenko, Brad S Kahl, Kami Maddocks, Natalie Sophia Grover, Keqin Qi, Lori Parisi, Katherine Daly, Angeline Zhu, Gilles Andre Salles
Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Narendranath Epperla, Jeffrey M Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie Sophia Grover, Stephanie P Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T Hill, Nilanjan Ghosh, Steven I Park, David A Bond, Mehdi Hamadani, Timothy S Fenske, Peter Martin, Jin Guo, Mary-Kate Malecek, Brad S Kahl, Christopher R Flowers, Brian L Link, Lawrence D Kaplan, David J Inwards, Andrew L Feldman, Eric D Hsi, Kami Maddocks, Kristie Blum, Nancy L Bartlett, James R Cerhan, John P Leonard, Thomas M Habermann, Matthew John Maurer, Jonathon B Cohen
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma. Blood advances (2022)
Elias Campo, Elaine S Jaffe, James R Cook, Leticia Quintanilla-Fend, Steven H Swerdlow, Kenneth C Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, Stefan Dirnhofer, Ahmet Dogan, Andrew L Feldman, Falko Fend, Jonathan W Friedberg, Philippe Gaulard, Paolo Ghia, Steven M Horwitz, Rebecca L King, Gilles Andre Salles, Jesús San F Miguel, John Francis Seymour, Steven P Treon, Julie M Vose, Emanuele Zucca, Ranjana Advani, Stephen Ansell, Wing-Yan Au, Carlos Barrionuevo, Peter Leif Bergsagel, Wing C Chan, Jeffrey I Cohen, Francesco d'Amore, Andrew John Davies, Brunangelo Falini, Irene M Ghobrial, Mariusz A Wasik, John G Gribben, Eric D Hsi, Brad S Kahl, Won-Seog Kim, Shaji K Kumar, Ann Steward LaCasce, Camille Laurent, Georg Lenz, John P Leonard, Michael P Link, Armando Lopez-Guillermo, Maria-Victoria Mateos-Manteca, Elizabeth A Macintyre, Ari M Melnick, Judith Trotman, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano A Pileri, Miguel Angel Piris, Barbara Pro, Vincent Rajkumar, Steven T Rosen, Birgitta Sander, Laurie Sehn, Margaret A Shipp, Sonali M Smith, Louis M Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H Wilson, Tadashi Yoshino, Pier Luigi Luigi Zinzani, Martin Dreyling, David W Scott, Jane N Winter, Andrew D Zelenetz
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood 140 (11) (2022)
Narendranath Epperla, Jeffrey M Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie Sophia Grover, Stephanie P Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T Hill, Nilanjan Ghosh, Steven I Park, David A Bond, Mehdi Hamadani, Timothy S Fenske, Peter Martin, Jin Guo, Mary-Kate Malecek, Brad S Kahl, Christopher R Flowers, Brian L Link, Lawrence D Kaplan, David J Inwards, Andrew L Feldman, Eric D Hsi, Kami Maddocks, Kristie Blum, Nancy L Bartlett, James R Cerhan, John P Leonard, Thomas M Habermann, Matthew John Maurer, Jonathon B Cohen
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma. Blood advances (2022)
Brad S Kahl
Management of Diffuse Large B-Cell Lymphoma: Are We Getting Smarter? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Sarah C Rutherford, Jun Yin, Levi D Pederson, Gabriela Perez Burbano, Betsy LaPlant, Mazyar Shadman, Hongli Li, Michael L LeBlanc, Vaishalee P Kenkre, Fangxin Hong, Kristie A Blum, Travis Dockter, Peter Martin, Sin-Ho Jung, Barbara Grant, Cara A Rosenbaum, Chaitra Ujjani, Paul M Barr, Joseph M Unger, Bruce D Cheson, Nancy L Bartlett, Brad S Kahl, Jonathan W Friedberg, Sumithra J Mandrekar, John P Leonard
Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Juan Pablo Alderuccio, Weiyun Z Ai, John Radford, Melhem Solh, Kirit M Ardeshna, Matthew A Lunning, Brian T Hess, Pier L Zinzani, Anastasios Stathis, Carmelo Carlo-Stella, Mehdi Hamadani, Brad S Kahl, David Ungar, Turk Kilavuz, Eric Yu, Yajuan Qin, Paolo F Caimi
Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study. Blood advances 6 (16) (2022)
Craig A Portell, Nolan A Wages, Brad S Kahl, L Elizabeth Elizabeth Budde, Robert W Chen, Jonathon B Cohen, Nikole E Varhegyi, Gina R Petroni, Michael E Williams
Dose Finding Study of Ibrutinib and Venetoclax in Relapsed or Refractory Mantle Cell Lymphoma. Blood advances (2021)
Grzegorz S Nowakowski, Fangxin Hong, David W Scott, William R Macon, Rebecca L King, Thomas M Habermann, Nina Wagner-Johnston, Carla Casulo, James L Wade, Gauri G Nagargoje, C M Reynolds, Jonathon B Cohen, Nadia Khan, Jennifer Effie Amengual, Kristy L Richards, Richard F Little, John P Leonard, Jonathan W Friedberg, Lale Kostakoglu, Brad S Kahl, Thomas E Witzig
Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (12) (2021)
Mehdi Hamadani, John Radford, Carmello Carlo-Stella, Paolo F Caimi, Erin G Reid, Owen A O'Connor, Jay M Feingold, Kirit M Ardeshna, William Townsend, Melhem Solh, Leonard T Heffner, David Ungar, Luqiang Wang, Joseph Boni, Karin Havenith, Yajuan Qin, Brad S Kahl
Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma. Blood 137 (19) (2021)
Victor Manuel Orellana-Noia, Daniel R Reed, Ashley Alesia McCook, Jeremy Michael Sen, Christian M Barlow, Mary-Kate Malecek, Marcus P Watkins, Brad S Kahl, Michael A Spinner, Ranjana Advani, Timothy J Voorhees, Anson Snow, Natalie Sophia Grover, Amy A Ayers, Jason T Romancik, Yuxin Liu, Scott F Huntington, Julio C Chavez, Hayder Saeed, Aleksander Lazaryan, Vikram Raghunathan, Stephen E Spurgeon, Thomas A Ollila, Christopher Del Prete, Adam Olszewski, Emily C Ayers, Daniel J Landsburg, Benjamin Echalier, Jun Lee, Manali Kamdar, Paolo F Caimi, Timothy Fu, Jieqi Liu, Kevin A David, Hanan Alharthy, Jennie Y Law, Reem Karmali, Harsh R Shah, Deborah M Stephens, Ajay Major, Alexandra E Rojek, Sonali M Smith, Amulya Yellala, Avyakta Kallam, Shazia Nakhoda, Nadia Khan, Mohammad Ahsan Sohail, Brain T Hill, Odeth Barrett-Campbell, Frederick Lansigan, Jeffrey M Switchenko, Jonathon B Cohen, Craig A Portell
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions. Blood (2021)
Brad S Kahl
BV for HL: can the responses last? Blood 128 (12) (2018)
Brad S Kahl, David T Yang
Follicular lymphoma: evolving therapeutic strategies. Blood 127 (17) (2016)